Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-20-019576

Options or other derivatives

  • VP Fin & Chief Acct Officer acquired 41,789 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Pietzke Steffen · VP Fin & Chief Acct Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-07-16 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +41,789 41,789 D
Loading xslF345X03/doc4.xml…